Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.
This study has been completed.
Study NCT01026701
Information provided by Janssen Korea, Ltd., Korea
First Received on December 3, 2009.
Last Updated on January 14, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
